Company Overview of VenomeTech SAS
VenomeTech SAS, a biotechnology company, engages in the exploitation of venom compounds for the development of novel therapeutics. The company offers outsourced research services, including biobank screening and peptide-based drug discovery; and technological platforms for biochemistry, functional assays, and peptide production. The company was founded in 2009 and is based in Valbonne, France.
473 Route des Dolines
Founded in 2009
33 4 92 96 03 11
33 4 92 96 07 44
Key Executives for VenomeTech SAS
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact VenomeTech SAS, please visit www.venometech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.